Sever Pharma Solutions AB Sustainability Reports
The company operates as a contract development and manufacturing organization (CDMO) for the pharmaceutical industry. It specializes in formulation development, clinical trial supply, and commercial manufacturing of highly potent drugs and controlled release systems.
Sector: Manufacturing
Country: Sweden
Exchange: Unlisted
LEI: 549300JGVU2I2AP30J71
2 reports from 2023 to 2024